The course of COVID-19 in allergic rhinitis patients receiving allergen spesific immunotherapy
E Atayik, G Aytekіn - medRxiv, 2022 - medrxiv.org
Introduction The aims of presenting study were trying to expose the course of SARS-CoV-2 (severe
acute respiratory syndrome-related coronavirus) in patients with allergic rhinitis (AR), …
acute respiratory syndrome-related coronavirus) in patients with allergic rhinitis (AR), …
Are allergic diseases a risk factor for systemic side effects after COVID-19 vaccines?
E Atayik, G Aytekіn - medRxiv, 2022 - medrxiv.org
Background/ aim Mass vaccination seems to be the most effective way to turn back to the pre-pandemic
period and end the pandemic. Unfortunately, COVID-19 vaccines have some …
period and end the pandemic. Unfortunately, COVID-19 vaccines have some …
Are high urea values before intravenous immunoglobulin replacement a risk factor for COVID-related mortality?
G Aytekіn, E Atayik - medRxiv, 2022 - medrxiv.org
Objective Since the World Health Organization accepted The Coronavirus Disease 2019 (COVID-19)
as a pandemic and there is still no effective treatment, it becomes crucial that the …
as a pandemic and there is still no effective treatment, it becomes crucial that the …
The efficacy of omalizumab treatment in patients with non-atopic severe asthma
E Atayik, G Aytekіn - medRxiv, 2022 - medrxiv.org
Introduction Non-atopic asthmatic patients generally have more severe clinical manifestations
frequently accompanied by chronic sinusitis and nasal polyps, with more limited …
frequently accompanied by chronic sinusitis and nasal polyps, with more limited …
[CITATION][C] Are allergic diseases a risk factor for systemic side effects after COVID-19 vaccines?(preprint)
E Atayik, G Aytekіn - 2022
Risk of adverse events of live-attenuated COVID-19 vaccination among atopic patients
C Chiewchalermsri, K Hengkrawit… - Journal of Asthma …, 2022 - Taylor & Francis
Purpose Atopic patients have more risk of adverse drug reactions. COVID-19 vaccination is
very important in the current situation. We still do not have data about risks of adverse effects …
very important in the current situation. We still do not have data about risks of adverse effects …
